{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:21:36Z","timestamp":1785522096395,"version":"3.56.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Key Research and Development Program of Shaanxi Province","award":["2024SF-YBXM-131"],"award-info":[{"award-number":["2024SF-YBXM-131"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biotechnol"],"DOI":"10.1186\/s12896-026-01162-w","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T09:33:59Z","timestamp":1779528839000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Knockdown of suppressor of glucose by autophagy (SOGA1) alleviates the progression of non-alcoholic steatohepatitis (NASH) by reducing hepatocyte senescence through regulating AMPK\/mTOR-mediated mitochondrial homeostasis"],"prefix":"10.1186","volume":"26","author":[{"given":"Lijing","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanhuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"issue":"1","key":"1162_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41575-023-00846-4","volume":"21","author":"G Feng","year":"2024","unstructured":"Feng G, Valenti L, Wong VW, Fouad YM, Yilmaz Y, Kim W, Sebastiani G, Younossi ZM, Hernandez-Gea V, Zheng MH. Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2024;21(1):46\u201356.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1162_CR2","doi-asserted-by":"publisher","first-page":"101231","DOI":"10.1016\/j.mam.2023.101231","volume":"95","author":"M Parola","year":"2024","unstructured":"Parola M, Pinzani M. Liver fibrosis in NAFLD\/NASH: from pathophysiology towards diagnostic and therapeutic strategies. Mol Aspects Med. 2024;95:101231.","journal-title":"Mol Aspects Med"},{"issue":"10","key":"1162_CR3","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/S2468-1253(24)00193-6","volume":"9","author":"H Hagstr\u00f6m","year":"2024","unstructured":"Hagstr\u00f6m H, Shang Y, Hegmar H, Nasr P. Natural history and progression of metabolic dysfunction-associated steatotic liver disease. Lancet Gastroenterol Hepatol. 2024;9(10):944\u201356.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"1162_CR4","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1097\/HEP.0000000000000604","volume":"79","author":"BP Lee","year":"2024","unstructured":"Lee BP, Dodge JL, Terrault NA. National prevalence estimates for steatotic liver disease and subclassifications using consensus nomenclature. Hepatology. 2024;79(3):666\u201373.","journal-title":"Hepatology"},{"issue":"2","key":"1162_CR5","doi-asserted-by":"publisher","first-page":"736","DOI":"10.7150\/thno.79876","volume":"13","author":"Y Lu","year":"2023","unstructured":"Lu Y, Li Z, Zhang S, Zhang T, Liu Y, Zhang L. Cellular mitophagy: Mechanism, roles in diseases and small molecule pharmacological regulation. Theranostics. 2023;13(2):736\u201366.","journal-title":"Theranostics"},{"key":"1162_CR6","doi-asserted-by":"crossref","unstructured":"Tsuji A, Yoshikawa S, Ikeda Y, Taniguchi K, Sawamura H, Morikawa S, Nakashima M, Asai T, Matsuda S. Tactics with prebiotics for the treatment of metabolic dysfunction-associated fatty liver disease via the improvement of mitophagy. Int J Mol Sci. 2023;24(6).","DOI":"10.3390\/ijms24065465"},{"issue":"4","key":"1162_CR7","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1002\/hep.32731","volume":"77","author":"D Loureiro","year":"2023","unstructured":"Loureiro D, Tout I, Narguet S, Bed CM, Roinard M, Sleiman A, Boyer N, Pons-Kerjean N, Castelnau C, Giuly N, et al. Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C, or nonalcoholic steatohepatitis. Hepatology. 2023;77(4):1348\u201365.","journal-title":"Hepatology"},{"issue":"5","key":"1162_CR8","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1080\/15548627.2024.2307215","volume":"20","author":"M Degli Esposti","year":"2024","unstructured":"Degli Esposti M. Did mitophagy follow the origin of mitochondria? Autophagy. 2024;20(5):985\u201393.","journal-title":"Autophagy"},{"issue":"12","key":"1162_CR9","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1007\/s00210-023-02636-w","volume":"396","author":"X Yang","year":"2023","unstructured":"Yang X, Zhang Y, Luo JX, Zhu T, Ran Z, Mu BR, Lu MH. Targeting mitophagy for neurological disorders treatment: advances in drugs and non-drug approaches. Naunyn Schmiedebergs Arch Pharmacol. 2023;396(12):3503\u201328.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"8","key":"1162_CR10","doi-asserted-by":"publisher","first-page":"e14199","DOI":"10.1111\/eci.14199","volume":"54","author":"M Forte","year":"2024","unstructured":"Forte M, D\u2019Ambrosio L, Schiattarella GG, Salerno N, Perrone MA, Loffredo FS, Bertero E, Pilichou K, Manno G, Valenti V, et al. Mitophagy modulation for the treatment of cardiovascular diseases. Eur J Clin Invest. 2024;54(8):e14199.","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"1162_CR11","doi-asserted-by":"publisher","first-page":"e14138","DOI":"10.1111\/eci.14138","volume":"54","author":"A Zimmermann","year":"2024","unstructured":"Zimmermann A, Madeo F, Diwan A, Sadoshima J, Sedej S, Kroemer G, Abdellatif M. Metabolic control of mitophagy. Eur J Clin Invest. 2024;54(4):e14138.","journal-title":"Eur J Clin Invest"},{"key":"1162_CR12","doi-asserted-by":"publisher","first-page":"216590","DOI":"10.1016\/j.canlet.2023.216590","volume":"582","author":"M Cao","year":"2024","unstructured":"Cao M, Tang Y, Luo Y, Gu F, Zhu Y, Liu X, Yan C, Hu W, Wang S, Chao X, et al. Natural compounds modulating mitophagy: Implications for cancer therapy. Cancer Lett. 2024;582:216590.","journal-title":"Cancer Lett"},{"issue":"8","key":"1162_CR13","doi-asserted-by":"publisher","first-page":"E1065","DOI":"10.1210\/jc.2015-1275","volume":"100","author":"TP Combs","year":"2015","unstructured":"Combs TP, Snell-Bergeon JK, Maahs DM, Bergman BC, Lamarche M, Iberkleid L, AbdelBaky O, Tisch R, Scherer PE, Marliss EB. Adiponectin-SOGA Dissociation in Type 1 Diabetes. J Clin Endocrinol Metab. 2015;100(8):E1065\u20131073.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1162_CR14","doi-asserted-by":"publisher","first-page":"e13590","DOI":"10.1111\/cpr.13590","volume":"57","author":"J Li","year":"2024","unstructured":"Li J, Yang F, Wang Z, Zheng S, Zhang S, Wang C, He B, Wang JB, Wang H. METTL16-mediated N6-methyladenosine modification of Soga1 enables proper chromosome segregation and chromosomal stability in colorectal cancer. Cell Prolif. 2024;57(5):e13590.","journal-title":"Cell Prolif"},{"issue":"10","key":"1162_CR15","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1074\/mcp.RA117.000011","volume":"16","author":"R Kruse","year":"2017","unstructured":"Kruse R, Krantz J, Barker N, Coletta RL, Rafikov R, Luo M, H\u00f8jlund K, Mandarino LJ, Langlais PR. Characterization of the CLASP2 Protein Interaction Network Identifies SOGA1 as a Microtubule-Associated Protein. Mol Cell Proteom. 2017;16(10):1718\u201335.","journal-title":"Mol Cell Proteom"},{"issue":"4","key":"1162_CR16","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1007\/s11033-019-04810-x","volume":"46","author":"A Habieb","year":"2019","unstructured":"Habieb A, Matboli M, El-Tayeb H, El-Asmar F. Potential role of lncRNA-TSIX, miR-548-a-3p, and SOGA1 mRNA in the diagnosis of hepatocellular carcinoma. Mol Biol Rep. 2019;46(4):4581\u201390.","journal-title":"Mol Biol Rep"},{"key":"1162_CR17","doi-asserted-by":"publisher","first-page":"125092","DOI":"10.1016\/j.chemosphere.2019.125092","volume":"241","author":"A Brulport","year":"2020","unstructured":"Brulport A, Vaiman D, Chagnon MC, Le Corre L. Obesogen effect of bisphenol S alters mRNA expression and DNA methylation profiling in male mouse liver. Chemosphere. 2020;241:125092.","journal-title":"Chemosphere"},{"issue":"10","key":"1162_CR18","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1136\/gutjnl-2019-319226","volume":"69","author":"GA Baselli","year":"2020","unstructured":"Baselli GA, Dongiovanni P, Rametta R, Meroni M, Pelusi S, Maggioni M, Badiali S, Pingitore P, Maurotti S, Montalcini T, et al. Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker. Gut. 2020;69(10):1855\u201366.","journal-title":"Gut"},{"key":"1162_CR19","doi-asserted-by":"publisher","first-page":"110522","DOI":"10.1016\/j.intimp.2023.110522","volume":"121","author":"T Ge","year":"2023","unstructured":"Ge T, Shao Y, Bao X, Xu W, Lu C. Cellular senescence in liver diseases: From mechanisms to therapies. Int Immunopharmacol. 2023;121:110522.","journal-title":"Int Immunopharmacol"},{"key":"1162_CR20","doi-asserted-by":"publisher","first-page":"101833","DOI":"10.1016\/j.arr.2022.101833","volume":"84","author":"Y He","year":"2023","unstructured":"He Y, Su Y, Duan C, Wang S, He W, Zhang Y, An X, He M. Emerging role of aging in the progression of NAFLD to HCC. Ageing Res Rev. 2023;84:101833.","journal-title":"Ageing Res Rev"},{"key":"1162_CR21","doi-asserted-by":"crossref","unstructured":"Wijayasiri P, Astbury S, Kaye P, Oakley F, Alexander GJ, Kendall TJ, Aravinthan AD. Role of hepatocyte senescence in the activation of hepatic stellate cells and liver fibrosis progression. Cells. 2022;11(14).","DOI":"10.3390\/cells11142221"},{"issue":"8","key":"1162_CR22","doi-asserted-by":"publisher","first-page":"100524","DOI":"10.1016\/j.jhepr.2022.100524","volume":"4","author":"SJ Wallace","year":"2022","unstructured":"Wallace SJ, Tacke F, Schwabe RF, Henderson NC. Understanding the cellular interactome of non-alcoholic fatty liver disease. JHEP Rep. 2022;4(8):100524.","journal-title":"JHEP Rep"},{"issue":"1","key":"1162_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jhep.2019.08.026","volume":"72","author":"Y Hazari","year":"2020","unstructured":"Hazari Y, Bravo-San Pedro JM, Hetz C, Galluzzi L, Kroemer G. Autophagy in hepatic adaptation to stress. J Hepatol. 2020;72(1):183\u201396.","journal-title":"J Hepatol"},{"issue":"4","key":"1162_CR24","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1152\/physrev.00058.2021","volume":"103","author":"JS Harrington","year":"2023","unstructured":"Harrington JS, Ryter SW, Plataki M, Price DR, Choi AMK. Mitochondria in health, disease, and aging. Physiol Rev. 2023;103(4):2349\u2013422.","journal-title":"Physiol Rev"},{"issue":"7","key":"1162_CR25","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.devcel.2021.02.009","volume":"56","author":"MYW Ng","year":"2021","unstructured":"Ng MYW, Wai T, Simonsen A. Quality control of the mitochondrion. Dev Cell. 2021;56(7):881\u2013905.","journal-title":"Dev Cell"},{"issue":"1","key":"1162_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13046-023-02732-y","volume":"42","author":"W Wei","year":"2023","unstructured":"Wei W, Zhang ZY, Shi B, Cai Y, Zhang HS, Sun CL, Fei YF, Zhong W, Zhang S, Wang C, et al. METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression. J Exp Clin Cancer Res. 2023;42(1):151.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"1162_CR27","doi-asserted-by":"publisher","first-page":"103910","DOI":"10.1016\/j.drudis.2024.103910","volume":"29","author":"S Wei","year":"2024","unstructured":"Wei S, Wang L, Evans PC, Xu S. NAFLD and NASH: etiology, targets and emerging therapies. Drug Discov Today. 2024;29(3):103910.","journal-title":"Drug Discov Today"},{"key":"1162_CR28","doi-asserted-by":"crossref","unstructured":"Dorairaj V, Sulaiman SA, Abu N, Abdul Murad NA. Nonalcoholic fatty liver disease (NAFLD): pathogenesis and noninvasive diagnosis. Biomedicines. 2021;10(1).","DOI":"10.3390\/biomedicines10010015"},{"issue":"2","key":"1162_CR29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/liv.14669","volume":"41","author":"J Lee","year":"2021","unstructured":"Lee J, Vali Y, Boursier J, Spijker R, Anstee QM, Bossuyt PM, Zafarmand MH. Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: A systematic review. Liver Int. 2021;41(2):261\u201370.","journal-title":"Liver Int"},{"issue":"10290","key":"1162_CR30","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212\u201324.","journal-title":"Lancet"},{"key":"1162_CR31","doi-asserted-by":"crossref","unstructured":"Engelmann C, Tacke F. The potential role of cellular senescence in non-alcoholic fatty liver disease. Int J Mol Sci. 2022;23(2).","DOI":"10.3390\/ijms23020652"},{"issue":"8","key":"1162_CR32","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.tem.2024.02.012","volume":"35","author":"X Fan","year":"2024","unstructured":"Fan X, Song Y, Zhao J. Evolving liver disease insights from NAFLD to MASLD. Trends Endocrinol Metab. 2024;35(8):683\u20136.","journal-title":"Trends Endocrinol Metab"},{"key":"1162_CR33","doi-asserted-by":"crossref","unstructured":"Zhang M, Bai X, Du Q, Xu J, Wang D, Chen L, Dong K, Chen Z, Yang J. The different mechanisms of lipid accumulation in hepatocytes induced by oleic acid\/palmitic acid and high-fat diet. Molecules. 2023;28(18).","DOI":"10.3390\/molecules28186714"},{"issue":"2","key":"1162_CR34","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jhep.2023.10.025","volume":"80","author":"Z Lei","year":"2024","unstructured":"Lei Z, Yu J, Wu Y, Shen J, Lin S, Xue W, Mao C, Tang R, Sun H, Qi X, et al. CD1d protects against hepatocyte apoptosis in non-alcoholic steatohepatitis. J Hepatol. 2024;80(2):194\u2013208.","journal-title":"J Hepatol"},{"issue":"13","key":"1162_CR35","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.7150\/thno.85369","volume":"13","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Zhang L, Ma Y, Xie L, Yang YY, Jin C, Chen H, Zhou Y, Song GQ, Ding J, et al. Secretome of senescent hepatic stellate cells favors malignant transformation from nonalcoholic steatohepatitis-fibrotic progression to hepatocellular carcinoma. Theranostics. 2023;13(13):4430\u201348.","journal-title":"Theranostics"},{"key":"1162_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jare.2022.08.006","volume":"47","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Yuan Y, Hu L, Tang J, Meng Z, Dai L, Gao Y, Ma S, Wang X, Yuan Y, et al. ANGPTL8 accelerates liver fibrosis mediated by HFD-induced inflammatory activity via LILRB2\/ERK signaling pathways. J Adv Res. 2023;47:41\u201356.","journal-title":"J Adv Res"},{"issue":"2","key":"1162_CR37","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3350\/cmh.2023.0045","volume":"29","author":"M Basheer","year":"2023","unstructured":"Basheer M, Naffaa M, Assy N. Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease. Clin Mol Hepatol. 2023;29(2):398\u2013400.","journal-title":"Clin Mol Hepatol"},{"key":"1162_CR38","doi-asserted-by":"crossref","unstructured":"Mikolasevic I, Domislovic V, Krznaric-Zrnic I, Krznaric Z, Virovic-Jukic L, Stojsavljevic S, Grgurevic I, Milic S, Vukoja I, Puz P, et al. The accuracy of serum biomarkers in the diagnosis of steatosis, fibrosis, and inflammation in patients with nonalcoholic fatty liver disease in comparison to a liver biopsy. Med (Kaunas). 2022;58(2).","DOI":"10.3390\/medicina58020252"},{"issue":"2","key":"1162_CR39","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/HEP.0000000000000937","volume":"81","author":"G Musso","year":"2025","unstructured":"Musso G, Pinach S, Mariano F, Saba F, De Michieli F, Framarin L, Berrutti M, Paschetta E, Parente R, Lizet Castillo Y, et al. Effect of phospholipid curcumin Meriva on liver histology and kidney disease in nonalcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial. Hepatology. 2025;81(2):560\u201375.","journal-title":"Hepatology"},{"issue":"2","key":"1162_CR40","first-page":"484","volume":"14","author":"J Park","year":"2023","unstructured":"Park J, Chen Y, Kim J, Hwang E, Park GH, Yang CH, Ryter SW, Park JW, Chung HT, Joe Y. CO-Induced TTP Activation Alleviates Cellular Senescence and Age-Dependent Hepatic Steatosis via Downregulation of PAI-1. Aging Dis. 2023;14(2):484\u2013501.","journal-title":"Aging Dis"},{"key":"1162_CR41","doi-asserted-by":"crossref","unstructured":"Zhang CY, Tan XH, Yang HH, Jin L, Hong JR, Zhou Y, Huang XT. COX-2\/sEH dual inhibitor alleviates hepatocyte senescence in NAFLD mice by restoring autophagy through Sirt1\/PI3K\/AKT\/mTOR. Int J Mol Sci. 2022;23(15).","DOI":"10.3390\/ijms23158267"},{"issue":"4","key":"1162_CR42","first-page":"1646","volume":"15","author":"H Wang","year":"2024","unstructured":"Wang H, Li X, Zhang Q, Fu C, Jiang W, Xue J, Liu S, Meng Q, Ai L, Zhi X, et al. Autophagy in Disease Onset and Progression. Aging Dis. 2024;15(4):1646\u201371.","journal-title":"Aging Dis"},{"issue":"2","key":"1162_CR43","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/15548627.2023.2254191","volume":"20","author":"Q Ren","year":"2024","unstructured":"Ren Q, Sun Q, Fu J. Dysfunction of autophagy in high-fat diet-induced non-alcoholic fatty liver disease. Autophagy. 2024;20(2):221\u201341.","journal-title":"Autophagy"},{"key":"1162_CR44","doi-asserted-by":"publisher","first-page":"176159","DOI":"10.1016\/j.ejphar.2023.176159","volume":"960","author":"D Zhang","year":"2023","unstructured":"Zhang D, Ma Y, Liu J, Wang D, Geng Z, Wen D, Chen H, Wang H, Li L, Zhu X, et al. Fenofibrate improves hepatic steatosis, insulin resistance, and shapes the gut microbiome via TFEB-autophagy in NAFLD mice. Eur J Pharmacol. 2023;960:176159.","journal-title":"Eur J Pharmacol"},{"issue":"51","key":"1162_CR45","doi-asserted-by":"publisher","first-page":"21581","DOI":"10.1021\/acs.est.3c05010","volume":"57","author":"J Liang","year":"2023","unstructured":"Liang J, Xu C, Xu J, Yang C, Kong W, Xiao Z, Chen X, Liu Q, Weng Z, Wang J, et al. PPAR\u03b1 Senses Bisphenol S to Trigger EP300-Mediated Autophagy Blockage and Hepatic Steatosis. Environ Sci Technol. 2023;57(51):21581\u201392.","journal-title":"Environ Sci Technol"},{"issue":"1","key":"1162_CR46","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12967-024-05060-7","volume":"22","author":"Y Yang","year":"2024","unstructured":"Yang Y, Qiu W, Xiao J, Sun J, Ren X, Jiang L. Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK\/PGC-1\u03b1 and PPAR\u03b1-mediated autophagy pathway. J Transl Med. 2024;22(1):309.","journal-title":"J Transl Med"},{"key":"1162_CR47","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.freeradbiomed.2024.04.214","volume":"219","author":"Y Chen","year":"2024","unstructured":"Chen Y, Yang F, Shi Y, Sheng J, Wang Y, Zhang L, Zhou J, Jin Y, Yan Y. RNF31 alleviates liver steatosis by promoting p53\/BNIP3-related mitophagy in hepatocytes. Free Radic Biol Med. 2024;219:163\u201379.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1162_CR48","doi-asserted-by":"publisher","first-page":"159570","DOI":"10.1016\/j.bbalip.2024.159570","volume":"1870","author":"S Chen","year":"2025","unstructured":"Chen S, Lu H, Yin G, Zhang X, Meng D, Yu W, Wang L, Liu H, Zhang F. Hesperitin prevents non-alcoholic steatohepatitis by modulating mitochondrial dynamics and mitophagy via the AMPK\u03b1-Drp1\/PINK1-Parkin signaling pathway. Biochim Biophys Acta Mol Cell Biol Lipids. 2025;1870(1):159570.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"1162_CR49","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.pbiomolbio.2023.10.002","volume":"185","author":"MI Khalil","year":"2023","unstructured":"Khalil MI, Ali MM, Holail J, Houssein M. Growth or death? Control of cell destiny by mTOR and autophagy pathways. Prog Biophys Mol Biol. 2023;185:39\u201355.","journal-title":"Prog Biophys Mol Biol"}],"container-title":["BMC Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12896-026-01162-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-026-01162-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-026-01162-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:10:15Z","timestamp":1785517815000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12896-026-01162-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1162"],"URL":"https:\/\/doi.org\/10.1186\/s12896-026-01162-w","relation":{},"ISSN":["1472-6750"],"issn-type":[{"value":"1472-6750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"22 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of the Second Affiliated Hospital of Xi\u2019an Jiaotong University (Approval Number: XJTU-2024027), and all animals received humane care in accordance with the guidelines of the National Institutes of Health. Clinical trials of this study were performed with approval from the Ethics Committee at the Second Affiliated Hospital of Xi\u2019an JiaoTong University (XJTU-2024027) and adhered to the principles of the Declaration of Helsinki. Informed written consent was obtained from all subjects.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"90"}}